Primary prevention of arterial thromboembolism in the oldest old with atrial fibrillation—a randomized pilot trial comparing adjusted-dose and fixed low-dose coumadin with aspirin-Reference-Cited by-同舟云学术

Primary prevention of arterial thromboembolism in the oldest old with atrial fibrillation—a randomized pilot trial comparing adjusted-dose and fixed low-dose coumadin with aspirin

Published:2006-01 Issue:1 Volume:17 Page:48-52
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Vemmos Konstantinos N.,Tsivgoulis Georgios,Spengos Konstantinos,Manios Efstathios,Xinos Konstantinos,Vassilopoulou Sofia,Zakopoulos Nikolaos,Moulopoulos Spyridon

Publisher

Elsevier BV

Subject

Internal Medicine

Reference8 articles.

1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials;Arch Intern Med,1994

2. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community;Sudlow;Lancet,1998

3. Atrial fibrillation in the elderly: facts and management;Chatap;Drugs Aging,2002

4. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications;Feinberg;Arch Intern Med,1995

5. Stroke prevention in atrial fibrillation study. Final results;Circulation,1991

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary Prevention After Cardioembolic Stroke;Ischemic Stroke Therapeutics;2024

2. Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure;Stroke;2021-10

3. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation;JAMA Cardiology;2017-03-01

4. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials;Heart;2016-09-01

5. Secondary Prevention After Cardioembolic Stroke;Ischemic Stroke Therapeutics;2016